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Abstract
Background: The traditional use of the oleo-gum-resin of Commiphora guidottii Chiov. ex. Guid., which is commonly
called scented myrrh, for topical treatment of wound is well documented. The major objective of the present study
was to investigate the essential oil and resin obtained from C. guidottii for their potential wound healing properties.
Due to their influence on the wound healing process, the anti-inflammatory and antimicrobial activities of scented
myrrh have also been investigated.
Methods: Powdered oleo-gum-resin of C. guidottii was steam-distilled to obtain essential oil, and the resin
was extracted from the marc with MeOH and filtered. The TLC fingerprint profile of the resin has been
recorded by using silica gel GF254 as stationary phase. The essential oil components were identified and
quantified by GC-MS. Ointments prepared from the essential oil (4 % v/w) and the resin (5 % w/w) were
used for wound healing activity tests. Toxicity of the formulated ointments was investigated according to
Draize skin irritation test. Acute anti-inflammatory effect in mice was evaluated using carrageenan induced
mouse hind paw oedema model. Antimicrobial activity tests were carried out using disk diffusion and broth
dilution techniques against 21 pathogenic bacterial and 4 fungal strains.
Results: Ointment formulations of both the oil and resin were found to be non-irritant at the concentrations used
and showed significant (p < 0.05-0.001) increase in wound contraction rate, shorter epithelization time and higher skin
breaking strength as compared to the negative control. Overall, the antibacterial and antifungal activities of the oil and
resin were comparable with the standard antibiotics ciprofloxacin and griseofulvin, respectively.
Conclusion: The results confirm that scented myrrh possesses genuine wound healing activity supporting the
traditional use of the plant.
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Background
The skin being a protective barrier against the outside
world, any break to it must be rapidly and efficiently
mended [1]. When acute wound healing does not progress
in an orderly and timely manner, complications can occur;
incisions can dehisce; hernias can form; anastomoses can
leak; and fistulae can develop [2]. Many of the available
drugs for wound management are not only expensive but
also pose problems such as allergy and drug resistance [3,
4]. By and large, phytomedicines for wound healing are not
only cheap and affordable, but are also safe. Thus, one-
third of all traditional medicines in use are for the treat-
ment of wounds and skin disorders, which is a very high
figure as compared to only 1–3 % of modern drugs [5].
Commiphora guidottii Chiov. ex. Guid. (Burseraceae)
is a shrub or tree growing up to 5 m tall; has greenish or
brownish peeling bark and is native to Ethiopia and
Somalia. It is fairly widespread in Somalia and in adja-
cent parts of Ogaden in Ethiopia. Its vernacular name is
“hadi” (sometimes spelled “hedi” or “hethi” by collectors)
in all areas where it is distributed. However, in Central
Somalia it is also known as “dunkaal”. The oleo-gum-
resin of C. gudottii, which is otherwise known as scented
myrrh, is commonly called “habakhadi” in Somalia and
“abeked” (Amharic) in Ethiopia [6], where it is added to
cattle feed to improve milk production. The Somali
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people also use it as a remedy for diarrhoea and stomach
complaints, to facilitate withdrawal of the placenta after
childbirth and for topical treatment of wounds [6–8].
Literature review reveals that the essential oil of C. gui-
dottii consists of mono- and sesquiterpens [9]. Bioassay
guided fractionation of the EtOAc extract of the resin re-
sulted in the isolation of the sesquiterpene (+)-T-cadinol,
as the major bioactive component of the plant with spas-
molytic and bactericidal effects [10, 11]. Although less po-
tent than T-cadinol with respect to their smooth muscle
relaxing properties in the rat aorta, additional minor com-
pounds such as cadinane, guaiane, oplopane and eudes-
mane were also isolated from the more polar fraction of
scented myrrh [12].
In an attempt to prove the traditional uses of scented
myrrh for the treatment of wounds, Claeson et al. [11]
investigated the antibacterial effects of its constituents
against Staphylococcus aureus, which is one of the most
common bacterial wound pathogens. Moreover, the use
of the plant by traditional healers in Somalia for the
treatment of general stomach complaints necessitated
the experimental assessment of the latex or its compo-
nents for their effects against cholera toxin-induced in-
testinal hyper secretion in mice [7] and also for their
inhibitory effects on contractile responses in the isolated
guinea-pig ileum [10]. The above studies confirmed that
the constituents of scented myrrh possess genuine bac-
tericidal and antidiarrhoeal activities. However, to date,
there appears to have been no report on scientific inves-
tigation of its wound healing properties.
The main objective of the present study was therefore
to evaluate the wound healing activity of the essential oil
and resin obtained from scented myrrh using in vivo
and in vitro experiments. Anti-inflammatory and anti-
microbial actions of these plant products have also been




The oleo-gum-resin of C. guidottii (gum opopponax
first grade), collected from Ogaden Region, in eastern
Ethiopia from September - October 2010, was pur-
chased from the Ethiopian Natural Gum Processing
and Marketing Enterprise (ENGPME), Addis Ababa,
Ethiopia. According to the enterprise, first grade refers
to the plant material that has passed through serious
grabbling processes and almost free from foreign mat-
ters and contaminants.
Experimental animals
Healthy Swiss albino mice of either sex (26–35 g and
age of 9–11 weeks) were procured from the animal
house of the Ethiopian Health and Nutrition Research
Institute (EHNRI) Addis Ababa, Ethiopia. Adult Wistar
albino rats (weighing 150–200 g and age of 10–11
weeks) were obtained from the animal house of the
School of Pharmacy (SoP), Addis Ababa University
(AAU). All animals were outbred strains but under-
gone several generations of inbreeding. They were not
subjected to any drug or test substance investigation
prior to the experiments, and were bred selectively in
the ratio of 1 male to 3 females, and kept in a 12 h
light/dark cycle and at room temperature, provided
with commercial pelleted ration and clean water ad
libitum. The animals were cared for feeding, watering,
housing, analgesia, and any health problems at all
time points and especially during experimental pe-
riods. They were acclimatized for one week before the
study, and during the experiment the animals were
housed individually in clean plastic cages in the SoP
animal house so as to avoid biting and possible
wound scratch to each other. All the animals survived
and were fit to conduct the experiments. They were
then assigned to either treatment or control groups
by simple random allotment using lottery method.
The same was done for treating animals within the
same group. All the experiments were conducted in
Pharmacognosy laboratory of SoP in accordance with
the internationally accepted laboratory animal use,
care and guideline [13] and approved by the institu-
tional Ethics Review Board of the SoP, AAU. At the
end of the experiment, animals were killed using cer-
vical dislocation.
Microbial strains
The samples were tested against the Gram-negative
bacterial strains: Escherichia coli CD/99/1, E. coli
K88, E. coli K99, E. coli 306, E. coli LT37, E .coli 872,
E. coli ROW 7/12, E. coli 3:37C, Salmonella typhi
Ty2, Shigella boydii D13629, S. dysentery 1, S. dysen-
tery 8, S. flexneri Type 6, S. soneii 1, Vibrio cholerae
85, V. cholerae 293, V. cholerae 1313 and V. cholerae
1315. The Gram-positive bacterial strains used were:
Bacillus pumilus 82, B. subtilis ATCC 6633 and
Staphylococcus aureus ML 267. All the bacterial strains
were procured from the Department of Technology,
Jadavpur University; Central Drugs Laboratory, Kolkata
and Institute of Microbial Technology, Chandigarh,
India. The stains were first checked for purity on the
basis of standard microbiological, cultural and bio-
chemical tests and then used for their sensitivity to-
wards the test samples.
Antifungal activity was performed on the fungal patho-
gens: Aspergillus niger ATCC 6275, Candida albican-
sATCC 10231, Penicillium funiculosum NCTC 287 and P.
notatum ATCC 11625. All the fungal strains were procured
from the Central Drugs Laboratory, Kolkata, India.
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Extraction and fractionation
Crushed air-dried oleo-gum-resin (200 g) of C. guidottii
was steam-distilled for 5 h to obtain the essential oil.
After removal of the oil, the marc left was extracted with
MeOH and filtered. The filtrate was then partitioned
(3×) with equal amount of n-hexane using a separatory
funnel, to remove the remaining oil components from
the resin. The methanolic layer was then dried in a dry-
ing oven at a temperature not exceeding 40 °C and the
percentage yield of the resin was calculated [14].
Thin layer chromatography (TLC)
TLC was run on analytical Silica gel 60 F254 (Merck)
plates using a mixture of toluene and EtOAc (98:2) as a
solvent system. The distance from the base line up to
the solvent front was adjusted to 8 cm and 10 µL each
of the resin (5 µL/mL in ethanol) and the reference
compound (thymol, 1 mg/mL in ethanol) were applied
2 cm from the bottom of the plate. After the plates
were developed, the spots were detected in day light or
under UV light of long wavelength (366 nm) after
spraying with anisaldehyde – sulfuric acid reagent
followed by heating at 110 °C for 10 min.
Gas chromatography-mass spectrometry (GC-MS)
Capillary GC-MS was performed on a Shimadzu 2010
(Shimadzu Co., Japan) using HP5-MS (Supreme-5 ms,
CS - Chromatographie Service GmbH, Langerwehe
Germany 30 m × 0.32 mm) column. Conditions: car-
rier gas hydrogen (1.5 mL/min); sample diluted with
MeOH (1:1000); splitless; injection temp. 300 °C; oven
40° for 3 min isothermal; 40-150° at 6° min-1; 150-
320º at 10 °C min-1 and then hold for 3 min. RIs
were calculated using co-chromatographed standard
n-alkanes (C9-C29). Compounds were identified by
mass spectral comparison with a commercial database
(Wiley 138 K mass spectral library) and laboratory’s own
database. Spectral data were compared with linear reten-
tion indices published in the literature [15–18].
Phytochemical analysis
The resin of C. guidottii was screened for secondary me-
tabolites such as flavonoids, terpenoids, polyphenols,
tannins, saponins and steroidal compounds according to
the method described in the literature [14, 19, 20].
Toxicity studies
Acute oral toxicity
Acute oral toxicity was studied according to the method
described by Gatsing et al. [21]. Briefly, Swiss albino
mice of either sex were divided into four groups of six
animals each. All animals were fasted for 15 h before ad-
ministration of the test samples. Animals were given 1000,
3000 and 5000 mg/kg of the resin to the corresponding
groups, by suspending the sample in 2 % Tween 80, while
the negative control group was given 2 % Tween 80 only.
The animals were observed for any behavioural changes
(like locomotion, reaction to noise, reaction to pinch, re-
activity and state of excrement) during the first 3 h after a
single oral dose administration of the test samples, and
were given free access to food and water. Deaths, if any,
were counted within the first 48 h after administration of
the extracts.
Skin irritation test
Skin irritation test was carried out using occluded der-
mal irritation test [22] with slight modification. Two
groups of rats (each group containing six animals) were
employed for this test and two areas on the dorsal side
of each rat on each side of the vertebrae (1 cm from the
midline of the vertebral column) were shaved and
marked before the experiment. One area was for test
sample ointment and the other was left untreated to be
used for comparison. Topical ointment preparation of
the oil and resin was applied to the respective group.
Immediately after, the area was covered by dressing
gauze over which a plastic sheet (occlusive material) was
placed. The covering was loosely held in contact with
the skin by means of a non-irritating adhesive tape and
tied across the diameter of the back of the rats with an
elastic bandage. After 24 h of exposure period, the elas-
tic bandage, the adhesive plaster, the plastic sheet and
the gauze were removed by taking care not to damage
the skin, and the test site was rinsed with distilled water.
The animals were examined for the presence of ery-
thema and oedema according to Draize dermal irritation
scoring system [23] at intervals of 1, 24, 48 and 72 h.
The degree of erythema and oedema was determined
based on the scores shown in Table 1.
Primary irritation index (PII) was calculated for the
test samples according to the formula shown below [22].




Very slight erythema (barely perceptible) 1
Well-defined erythema 2
Moderate to severe erythema 3
Severe erythema (beef redness) 4
Oedema formation Value
No oedema 0
Very slight oedema (barely perceptible) 1
Slight oedema (edges of area well-defined by definite raising) 2
Moderate oedema (raised approximately 1 mm) 3
Severe oedema (extending beyond the area of exposure) 4
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PII ¼
P
Erythema at 1; 24; 48 and 72hð Þ
No of test sites  4 scoring intervals
þ
P
Oedema at 1; 24; 48 and 72hð Þ
No of test sites  4 scoring intervals
If irreversible alteration of the dermal tissue is noted
in any animal, which include ulceration and clear necro-
sis or signs of scar tissue, the test item is classified as
corrosive in which case Draize classification was not
applicable.
Ointment formulation
Simple ointment base was prepared according to the
British Pharmacopoeia [24] using hard paraffin, cetos-
tearyl alcohol, white soft paraffin and wool fat. The es-
sential oil (4 mL) and the resin (5 g) were separately
incorporated into portions of the simple ointment to
make 4 % (v/w) oil and 5 % (w/w) resin ointments of
uniform consistency and smooth texture.
In vivo wound healing models
Excision wound model
Four groups of rats of either sex containing six per
group (3 male and 3 female) were anaesthetized with
diethyl ether. Diethyl ether was used as inhalational
anesthesia using desiccators, and depth of anesthesia
was monitored using vital reflexes. Circular wound of
area 540 mm2 was inflicted and left undressed. Then,
4 % (v/w) essential oil ointment or 5 % (w/w) resin
ointment for the experimental groups; 0.2 % (w/v)
nitrofurazone ointment and simple ointment BP for
the positive and negative control groups, respectively,
were topically applied on a daily basis until the
wound healed completely. Wound contraction was
assessed by tracing the wound area on transparent
paper (subsequently transferring it to a graph paper)
every other day, and the change in wound area was
calculated [25]:




where, healed area = original wound area (540 mm2) –
present wound area.
Number of days required for complete falling of scab
without any residual raw wound, which indicates the
period of epithelization, was noted [26].
Incision wound model
Five groups of mice containing six animals in each group
were anaesthetized and longitudinal paravertebral inci-
sions were made 1 cm from the midline of the vertebral
column [27]. A full aseptic measure was not taken and no
local or systemic antimicrobials were used throughout the
experiment. The wound was closed with interrupted suture,
1 cm apart with the help of black silk surgical thread and
straight needle [26]. Ointments of the oil (4 %, v/w) or the
resin (5 %, w/w) were applied topically on the respective
test groups, while 0.2 % (w/v) nitrofurazone and simple
ointment were applied for the positive and negative con-
trols, respectively, for ten days (on a daily basis). This was
done every morning at 9:00 a.m. One of the five groups
was left untreated. The suture was removed on the 7th day
and skin breaking strength was measured by continuous
water flow method on day 10 after the animals were eutha-
nized [25, 28]. Percentage of tensile strength was calculated
using the following formula [29]:
%Tensile strength TSð Þ of test sample ¼ TS of test sample‐TS s:o
TS s:o
 100
%Tensile strength TSð Þ of reference ¼ TS of reference‐TS s:o
TS s:o
 100
%Tensile strength TSð Þ of s:o ¼ TS s:o‐TS l:u
TS l:u
 100
where, s.o and l.u stand for simple ointment treated and
left untreated groups, respectively.
Hydroxyproline assay
Hydroxyproline (0.05 g) was dissolved in water and di-
luted to about 400 mL with water. Concentrated HCl
(20 mL) was added and the solution was made up to
500 mL with water. The solution (100 µg/mL) was then
diluted to give 5, 10 and 15 μg of hydroxyproline/mL.
Triplicate solutions of each of these concentrations and
blank solutions were prepared. One ml of 0.05 M CuSO4
was added into each test tube, followed by the addition
of 1 mL of 2.5 N NaOH, and the tube contents were
mixed by gentle swirling. The tubes were placed in a
water bath at 40 °C for about 5 min and then 1 mL of 6 %
H2O2 was added. The tubes were left in a bath for 10 min
with occasional swirling and cooled with tap water, then
4 mL of 3 N H2SO4 and 2 mL of 5 % dimethylaminoben-
zaldehyde (DMAB) solution were added by swirling after
each addition. Caps were placed on tubes, which were
kept in a water bath at 70 °C for 16 min. The solutions
were cooled, mixed and their absorbance measured
against the blank solution at wavelength of 572 nm in
1 cm cells [30] and calibration curve was constructed.
Hydroxyproline assay was performed by inducing cir-
cular wound with approximate area of 300 mm2 using
the procedure described in excision wound model. The
wounds were treated with topical application of the oil,
resin, 0.2 % nitrofurazone or simple ointment for 10 days
[28]. On the 11th post wounding day, the animals from
each group were euthanized and the wound tissue was
excised, weighed, and dried in an oven at 70 °C for 18 h,
and the dry weights were noted. The tissues were treated
in the same way as the standard hydroxyproline was
Gebrehiwot et al. BMC Complementary and Alternative Medicine  (2015) 15:282 Page 4 of 11
treated, and absorbance was measured at 572 nm using
a spectrophotometer (Jenway Model 6500, England).
The amount of hydroxyproline in the samples was calcu-
lated by using the following equation, which was ob-
tained from the calibration curve of the standard
hydroxyproline [31]:
A ¼ 0:0058 Cþ 0:0067 OR C ¼ A‐0:0067
0:0058
where, A is absorbance and C is concentration.
Anti-inflammatory activity
Mouse paw oedema model was used to determine the
acute anti-inflammatory activity of the test substances.
Following overnight fasting with free access to water, the
basal volume of the right hind paw of each mouse was
determined before administration of any drug using
plethysmometer (Ugo Basile, 7140 Italy) [32]. Then, the
animals were divided into five groups (six animals per
group), such that the mean volumes of the different
groups were similar. Vehicle, the standard drug (indo-
methacin 10 mg/kg), and the resin in three dose levels
(150, 300 and 600 mg/kg) were administered orally to
the respective group, 1 h before carrageenan injection.
The resin and indomthacin were separately suspended in
2 % Tween 80. Paw swelling was induced by sub-plantar
injection of 0.05 mL of 1 % carrageenan in 0.9 % saline
(w/v) into the right hind paw. Thereafter, paw oedema
was measured at 1, 2, 3 and 4 h after carrageenan injec-
tion using plethysmometer [33]. Percent inhibition of
oedema was calculated using the formula:






Zones of inhibition produced by the samples were de-
termined by disc diffusion technique, and compared
with those produced by ciprofloxacin [34]. The resin
and the oil were separately dissolved in dimethylsulfox-
ide (DMSO), (DMSO was found to be inactive at the
concentration used). Serial nutrient agar plates were
prepared and incubated at 37 °C for 24 h to check for
any contamination. Sterile filter paper discs of 6 mm
diameter were soaked in stock solution (200 µg/mL) of
the samples (each 6 mm disc was shown to absorb
25 µL of the sample solution of reference drug stock
solution in order to be saturated) and placed in the ap-
propriate position on the surface of the plate flooded
with 24 h old culture grown on nutrient broth, marked
as quadrant on the back of the Petri dishes. They were
then incubated at 37 oC for 24 h and the diameters of
zone of inhibition were measured in mm. A similar
procedure was adopted for pure ciprofloxacin (dissolved
in water at a concentration of 200 µg/mL) and the zone of
inhibition was compared accordingly. The minimum in-
hibitory concentrations (MICs) of the test samples were
also determined by the checkerboard technique using
nutrient agar media [35].
Antifungal test
Antifungal activity was first evaluated by estimation of the
MIC of the test substances against the fungal pathogens,
followed by the disc diffusion method, using griseofulvin
(at a concentration of 2000 µg/mL) as a reference stand-
ard on Sabourds Dextrose Agar (SDA) medium according
to CLSI [36]. The concentrations selected for MIC deter-
mination ranges from 50 to 2000 µg/mL and the zones of
inhibition were studied at the highest MIC value as de-
scribed by Mitchell and Carter [34].
Statistical analysis
Raw data obtained from most of the experiments were
expressed as mean ± SEM (standard error of the mean).
Results were statistically analyzed using Microsoft excel
2010 and one-way ANOVA followed by Post Hoc Tukey
and Dunnett t-tests using SPSS version 20 software. Re-
sults were considered as significant at P < 0.05.
Results
Extraction and chromatography
Steam distillation of the oleo-gum-resin of C. guidottii
followed by maceration with methanol yielded a pale
yellow oil (2.8 % v/w), and a reddish brown resin (39 %
w/w), respectively. Preliminary phytochemical screening
indicated the presence of terpenoids, steroids and
phenolic compounds in the resin. These results were
consistent with previous report of Hanuš et al. [9]. TLC
fingerprint profile of the resin is depicted in Fig. 1.
Chemical composition of the essential oil of C. guidottii
was studied using GC-MS and the results are summa-
rized in Table 2.
The relative percentage of the 29 compounds (about
98.98 % of the oil) identified in the oil is also shown.
Toxicity studies
In acute toxicity study, the resin killed more than 50 %
of the animals at a dose of 5000 mg/kg, while no mortal-
ity was observed at a dose of 3000 mg/kg, except for
some decrease in locomotor activity. This indicates that
the dose causing 50 % death of the animals (LD50) is
near 3000 mg/kg, indicating good safety margin. This re-
sult complements the previous report which confirmed
that the non-polar extracts of the resins of C. guidottii
are non-toxic to experimental animals up to the tested
dose of 1.2 g/kg [37].
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Both the formulated oil and resin of C. guidottii were
found to cause no erythema or oedema. Therefore, their
PII values were zero implying the non irritant nature of the
test samples as per the dermal irritation scoring system of
Draize [23] and Environmental Protection Authority [36].
Wound healing activity
Wound contraction and period of epithelization
In the present study, diethyl ether was used as an anaes-
thetic agent because of its availability, rapid recovery, re-
turn from anaesthetic hypothermia, lower incidence of
death, quick elimination from the lungs and relative
technical ease of administration. Moreover, diethyl ether
has a smaller impact on the receptors located in the
membrane of erythrocytes maintaining a stable immune
function in mice, which is a big advantage to our work
since immunosuppression could have seriously affected
our results.
As shown in Fig. 2, wound contraction was promoted
till day 16 in both test substance and standard ointment
treated groups. The test samples facilitated wound con-
traction significantly (p < 0.05) from day 8 to 16 as com-
pared to the negative control, and the difference was
insignificant with nitrofurazone. Time for complete epi-
thelization was significantly (p < 0.05) shorter in test
sample and nitrofurazone treated groups as compared to
the negative control (Table 3). However, there was no
significant difference between nitrofurazone and resin,
between nitrofurazone and the oil, and between resin
and the oil.
Tensile strength
The wound breaking strength of all animals treated with
test samples showed significant (p < 0.05) difference when
Fig. 1 TLC fingerprint profile of the resin of Commiphora
guidottii(solvent system: toluene/EtOAc (98:2); spray reagent
anisaldehyde – sulfuric acid reagent); R: Reference (thymol): (a) under
visible light after spray and (b) under UV light of 366 nm after spray
Table 2 Composition of the essential oil of Commiphora
gudottii oleo-gum-resin
No. Compounda RIb Percentage
1 cis-β-Ocimene 1038 0.15
2 trans-β-Ocimene 1044 6.71
3 Rosefuran 1100 0.26
4 α-Pinene oxide 1101 0.47
5 6-Methyl-3,5-heptadiene-2-one 1104 0.29
6 Limona ketone 1125 1.19
7 cis-Myroxide 1141 0.67
8 Limonen-10-ol 1288 0.50
9 1-Decanol 1328 0.53
10 α-Copaene 1374 0.18
11 β -Bourbonene 1387 0.61
12 β-Elemene 1389 3.87
13 α-Santalene 1416 19.54
14 trans-α-Bergamotene 1432 9.30
15 α-Humulene 1452 0.45
16 cis-β-Farnesene 1454 0.62
17 β-Santalene 1462 0.71
18 Germacrene D 1484 0.75
19 Sesqiterpenec 1494 2.29
20 α-Selinene 1498 0.97
21 Curzerene 1499 11.38
22 α-Bisabolene 1506 2.33
23 Sesqiterpenec 1570 1.23
24 Sesqiterpenec 1611 4.77
25 108, 214, 274c 1626 0.98
26 Furanoeudesma-1,3-diene 1654 18.63
26 Isofuranodiene 1658 6.76
27 Furanodiene 1690 1.28
28 8-α-Ethoxyisofuranodiene 1705 0.96
29 8-α-Methoxyfurandione 1848 0.60
Total (%) 98.98
aCompounds listed in order of elution; bRI (retention index) measured relative
to n-alkanes (C9–C28) on HP5-MS column under conditions listed in the
Experimental section; cCompound not identified (figures represent prominent
peaks in the mass spectrum)
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compared to the animals that are left untreated. Particu-
larly, the resin showed significant (p < 0.05) difference in
tensile strength when compared to the simple ointment
treated groups. Animals treated with simple ointment in-
creased the tensile strength by about 19.73 %, which failed
to reach statistical significance, when compared to the un-
treated controls (Table 4).
Hydroxyproline assay
Table 5 shows the hydroxyproline content in the granu-
lation tissues of the test animals on day 11. Hydroxypro-
line levels of oil and resin ointment treated groups were
significantly (p < 0.05) increased as compared to the sim-
ple ointment treated group.
Anti-inflammatory activity
After administration of carrageenan, resin and indo-
methacin treated animals showed significant (p < 0.001)
reduction of oedema as compared to the negative con-
trol (Table 6). However, there was no significant differ-
ence with the standard drug indomethacin in any course
of the study.
Antimicrobial activity
Zone of inhibition and MIC values of the resin and oil
against different bacterial strains are shown in Table 7.
The Gram‐negative bacteria including all strains of E.
coli and V. cholerae, as well as S. typhi Ty2 were found
to be the most inhibited bacterial pathogens by both the
oil and resin of C. guidottii. The remaining Gram‐nega-
tive bacterial strains namely, all strains of Shigella and
the Gram‐positive bacterial strains: B. pumilus, and B.
subtilis were inhibited moderately. The oil and resin also
exhibited good antibacterial effect against S. aureus with
MIC values of 25 and 50 µg/mL, respectively. In general,
the test substances showed low MIC (≤100 µg/mL)
values against most of the tested pathogenic bacterial
strains indicating their broad spectrum of action.
Similarly, the antifungal activity was studied and their
MIC values determined (Table 8). Lowest MIC value was
recorded for the oil (400 µg/mL) on C. albicans ATCC
10231. Overall, both the oil and the resin were 68.8 – 88.9
% as active as the standard antifungal agent griseofulvin.
Fig. 2 Percentage contraction of the wound of animals treated with ointments containing 4 % (v/w) essential oil or 5 % (w/w) resin of Commiphora
guidottii (*Significant (p < 0.05); CGO: C. guidottii essential oil; CGR: C. guidottii resin; SO: Simple ointment)
Table 3 Effect of topical application of ointments containing 4
% (v/w) essential oil or 5 % (w/w) resin of Commiphora guidottiion
wound epithelization period of excision wound model in
comparison with nitrofurazone and simple ointments
Group Period of epithelization (day)
Essential oil 22.42 ± 0.61*
Resin 23.50 ± 0.72*
Nitrofurazone 20.67 ± 0.33**
Simple ointment 25.67 ± 0.42
*The mean value is significant (p < 0.01) and (**p < 0.001) when compared with
simple ointment treated group; N = 6; Results are expressed as mean ± SEM
Table 4 Effect of topical application of ointments containing
4 % (v/w) essential oil or 5 % (w/w) resin of Commiphora
guidottiion wound tensile strength of incision wound model
in comparison with nitrofurazone and simple ointment
Group Tensile strength (g) % Tensile strength
Essential oil 234.67 ± 23.40* 29.42
Resin 293.83 ± 53.50*a 78.17
Left untreated 123.00 ± 0.41 -
Nitrofurazone 319.83 ± 32.26*a 117.08
Simple ointment 147.33 ± 9.0 19.73
*The mean difference is significant (p < 0.05) when compared to the left
untreated group; awhen compared to the simple ointment treated group;
N = 6; Results are expressed as mean ± SEM
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Discussion
Characteristic TLC fingerprinting of an extract not only
helps in the identification and quality control of a particu-
lar plant species but also provides vital information for
isolation and identification of chemical marker(s). Thus,
TLC fingerprint of the resin of C. guidottii given in this
work may serve as a reference for proper authentication,
standardization and quality control of the plant drug. GC-
MS analysis confirmed that the major constituents of the
essential oil of C. guidottii is α-santalene, although
furanoeudesma-1,3-diene and curzerene also occurred in
large amounts (Table 2). Previous report by Craveiro et al.
[38] indicates that α-santalene along with α-bisabolene
and furanodiene are the major components of the oil.
However, in the present study the later two compounds
were detected in lesser amounts.
The wound contraction ability of the oil and resin of
scented myrrh observed in this study indicates that the
plant possesses a definite pro-healing action, since 88 %
of the healing of wound occur due to contraction, and
the other 22 % occur due to scar formation [39]. One
reason for the wound contraction ability of these plant
products could be through enhancing the proliferation
of epithelial cells [40]. On the other hand, since incision
wound treated with the test samples showed greater ten-
sile strength as compared to the negative control, it
might be inferred that the test samples not only in-
creased collagen synthesis per cell, but also aided in cross-
linking of the proteins [3, 26, 41]. The common method
of collagen determination is based on the quantification of
hydroxyproline which accounts for approximately 10 % of
the collagen molecule [42, 43]. It is known that collagen
accumulation is the sum of synthesis and destruction oc-
curring simultaneously during wound healing process
[44]. Therefore, the increased amount of hydroxyproline
in the study groups indicates increased collagen content
whereas, collagen content in the negative control group
was relatively smaller, which might be due to a prolonged
inflammatory phase, where the degradation of collagen is
greater than its synthesis.
Inflammation induced by carrageenan develops im-
mediately following injections, and produces three dis-
tinct phases. The first phase (0–1.5 h) is mediated by
histamine and serotonin. The second phase (1.5–2.5 h)
is mediated by bradykinin, while prostaglandins are im-
plied in the third phase (2.5–5 h). The third phase of
oedema is sensitive to most clinically effective anti-
inflammatory drugs, which have been frequently used
to assess the antioedematous effect of natural products
[33, 45]. Accordingly, the resin of C. guidottii showed
higher percentage inhibition of oedema formation (>50 %)
3 h after injection of carrageenan, which may lead to a
conclusion that its anti-inflammatory activity is through
inhibition of prostaglandin synthesis.
As shown in Table 7, both the resin and essential oil
of C. guidottii displayed broad spectrum antibacterial ac-
tivity. However, their activity against the Gram‐negative
bacteria tested was much higher than their effect against
the Gram-positive ones. Generally, Gram‐negative bac-
teria are more resistant to antimicrobial agents since
they are covered with a phospholipid membrane, carry-
ing the structural lipopolysaccharide component that
makes their cell wall impermeable to antimicrobial sub-
stances [46]. In the present study, however, higher
activity was noted against the Gram-negative bacteria.
This might be due to the ability of scented myrrh con-
stituents to affect the overall impermeability and integ-
rity of the bacterial cell wall. In general, the activity
obtained may be regarded as highly significant, since
plant extracts having MIC values ≤ 8000 µg/mL are
considered to be effective antibacterial agents [47]. It is
particularly interesting to note that both the oil and
resin showed good activity against S. aureus (MIC = 25
and 50 µg/mL, respectively), which is one of the most
Table 5 Effect of topical application of ointments containing
4 % (v/w) essential oil or 5 % (w/w) resin of Commiphora guidottii
on dry weight and hydroxyproline content of the granulation tissue
in comparison with nitrofurazone and simple ointment
Group Dry weight (g) Hydroxyproline (μg/g of tissue)
Essential oil 41.56 ± 5.71 77.50 ± 2.46*
Resin 63.12 ± 14.18 63.10 ± 2.61*
Nitrofurazone 44.60 ± 5.01 134.50 ± 14.82*
Simple ointment 30.38 ± 2.18 34.00 ± 1.13
*The mean difference is significant (p < 0.05) when compared to the control
group; N = 6; Results are expressed as mean ± SEM
Table 6 Anti-inflammatory activity of the resin of Commiphora guidottii on carrageenan-induced mice paw oedema
Test substance Dose (mg/kg) Percent oedema inhibition
1 h 2 h 3 h 4 h
150 9.84 ± 0.02 32.86 ± 0.04* 36.23 ± 0.05* 53.85 ± 0.03*
Resin 300 21.16 ± 0.007* 44.98 ± 0.005* 54.83 ± 0.005* 60.05 ± 0.009*
600 17.20 ± 0.006* 41.10 ± 0.007* 52.90 ± 0.008* 65.44 ± 0.008*
Indomthacin 10 27.78 ± 0.008* 55.00 ± 0.006* 68.84 ± 0.008* 86.52 ± 0.006*
Vehicle - 19.05 ± 0.002 30.14 ± 0.006 26.06 ± 0.005 25.00 ± 0.006
*The mean value is significant (p < 0.001) when compared with the negative control group; N = 6; Results are expressed as mean ± SEM
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common bacterial wound pathogens. The antifungal
activity of the test samples is also very important in
wound healing since fungal superinfection may be
present in some cases. More often than not, topical
agents providing both antibacterial and antifungal
activity are highly desired for wound healing [48].
Postoperative wounds are known to be complicated by
infection ultimately delaying angiogenesis [49, 50]. Mi-
crobes can also cause poor quality granulation tissue
formation, reduced tensile strength of connective tissue,
impaired epithelization and odor [51].
When we look at the phytoconstituents, the wound
healing activity of C. guidottii is likely to be attributed to
its high content of terpenoids, since terpenoids are
known to promote the wound healing process, mainly
due to their astringent and antimicrobial properties,
which could be responsible for wound contraction and
increased rate of epithelization [20]. Sesquiterpene lac-
tones are known to possess antioxidant activity, which
may contribute to the wound healing process [49] and
triterpenes are also responsible for promotion of rapid
wound healing [50].
Table 7 Minimum inhibitory concentrations (MICs) and zones of inhibition (at a concentration of 200 μg/mL around a 6 mm disc
diameter) of the essential oil and resin of Commiphora guidottii as compared with ciprofloxacin
Bacterial strain MIC (μg/mL)* Zone of inhibition (mm)
Oil Resin Oil** Resin** Ciprofloxacin.
Bacillus pumilus 82 50 200 10.5 (55.3) 11.0 (57.9) 19.0
B. subtilis ATCC6633 100 200 10.0 (55.6) 11.0 (61.1) 18.0
Escherichia coli 3:37C 25 25 14.5 (93.5) 14.5 (93.5) 15.5
E. coli 306 25 25 15.5 (93.9) 14.5 (87.9) 16.5
E. coli 872 25 25 15.5 (96.9) 14.0 (87.5) 16.0
E. coli CD/99/1 25 25 16.0 (94.1) 15.0 (88.2) 17.0
E. coli K88 25 25 16.5 (97.1) 14.5 (85.3) 17.0
E. coli K99 25 25 16.5 (97.1) 14.0 (85.3) 16.0
E. coli LT37 25 25 15.0 (93.8) 14.0 (87.5) 16.0
E. coli ROW 7/12 25 25 16.0 (97.0) 14.0 (84.8) 16.5
Salmonella typhi Ty2 10 25 15.5 (96.9) 16.0 (100.0) 16.0
Shigella boydii D13629 50 100 16.5 (82.5) 14.5 (72.5) 20.0
S. dysentery 1 50 100 16.5 (80.5) 14.5 (70.7) 20.5
S. dysentery 8 50 100 17.0 (81.0) 14.5 (69.0) 21.0
S. flexneri Type 6 50 100 16.5 (80.5) 15.0 (73.2) 20.5
S. soneii 1 50 100 16.0 (82.1) 14.0 (71.8) 19.5
Staphylococcus aureus ML 267 25 50 11.0 (61.1) 15.0 (83.3) 18.0
Vibrio cholerae 85 10 25 16.5 (91.7) 16.0 (88.9) 18.0
V. cholerae 293 10 25 16.5 (94.3) 16.0 (91.4) 17.5
V. cholerae 1313 10 25 16.0 (94.1) 15.5 (91.2) 17.0
V. cholerae 1315 10 25 17.0 (94.4) 16.5 (91.7) 18.0
*MICs are expressed as an average from three independent experiments, each performed in triplicate. **Values in parenthesis indicate % activity of the test
samples compared with that of ciprofloxacin
Table 8 Minimum inhibitory concentrations (MICs) and zones of inhibition (at a concentration of 2000 μg/mL around a 6 mm disc
diameter) of the essential oil and resin obtained from Commiphora guidottii against four fungal strains
Fungal strain MIC (μg/mL)* Zone of inhibition (mm)
Oil Resin Oil** Resin** Griseofulvin
Aspergillus niger ATCC 6275 1000 1500 12.5 (83.3) 11.0 (73.3) 15
Candida albicans ATCC 10231 400 1000 14.0 (87.5) 11.0 (68.8) 16
Penicillium funiculosum NCTC 287 1000 2000 12.0 (85.7) 10.0 (71.4) 14
P. notatum ATCC 11625 1000 2000 12.0 (88.9) 10.5 (77.8) 13.5
*MIC are expressed as an average from three independent experiments, each performed in triplicate. **Values in parenthesis indicate % activity of the test
samples as compared with that of the standard griseofulvin
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According to Biswas et al. [51], an ideal drug for
wound should fulfill the criteria such as rapid con-
traction of wound leading to quick healing, reduction
of wound epithelization time and appreciable gain of
tensile strength. It has been reported that a plant
based remedy should affect at least two different pro-
cesses of wound healing before it can be said to have
some scientific support for its traditional use as a
wound healing agent [52]. In this regard, it is fair to
say that the formulated ointments of C. guidotti oil
and resin fulfill these criteria as they increased wound
contraction and tensile strength besides reducing epi-
thelization time. These results together with the
genuine anti-inflammatory and antimicrobial effects
observed make these plant products candidates for
the development of efficient wound healing drugs, al-
though the reproducibility of some of the experiments
could to some degree be affected by the subjectivity
involved in some of the observations like skin irrita-
tion test and determination of period of epithelization.
Conclusion
From the foregoing, it can be concluded that the
wound-healing potential of scented myrrh may be attrib-
uted in full or in part to the presence of terpenoids,
which may act individually or possess additive effect that
accelerates the healing process. Furthermore, the broad
spectrum antimicrobial activities of the oil and the resin
as well as the anti-inflammatory effect of the resin may
contribute to the overall wound healing capacity of the
plant. In view of close similarities between rodents and
human biology, and the relative safety of the resin in
mice coupled with the mere absence of irritation upon
topical application of the formulated ointments on the
skin, scented myrrh could be a good candidate for the
preparation of natural therapeutic agents for wound
management, supporting the its traditional use as a rem-
edy for wounds. However, further studies on histology of
tissue obtained from treated group and the expression of
growth factors are highly warranted to show the changes
in the tissue architectures at different stages of wound
healing and to understand the mechanism of action of the
resin and the oil in wound healing process, respectively.
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